These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36473941)

  • 1. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
    Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
    J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
    Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
    BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the postload-fasting glucose gap be used to determine risk of developing diabetes in chinese adults: A prospective cohort study.
    Xu X; Wang D; Jaffar S; Alam U; Qiu S; Xie B; Zhou X; Sun Z; Garrib A
    Diabetes Res Clin Pract; 2024 Jul; 213():111761. PubMed ID: 38950783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
    Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
    Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting heart rate and the risk of incident type 2 diabetes mellitus among non-diabetic and prediabetic Iranian adults: Tehran lipid and glucose study.
    Moazzeni SS; Karimi Toudeshki K; Ghorbanpouryami F; Hasheminia M; Azizi F; Pishgahi M; Hadaegh F
    BMC Public Health; 2023 Oct; 23(1):2112. PubMed ID: 37891510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study.
    Asgari S; Masrouri S; Khalili D; Azizi F; Hadaegh F
    Front Cardiovasc Med; 2022; 9():1018403. PubMed ID: 36386371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
    Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes.
    Sasaki N; Ozono R; Maeda R; Higashi Y
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32933951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
    Alizadeh Z; Baradaran HR; Kohansal K; Hadaegh F; Azizi F; Khalili D
    Front Endocrinol (Lausanne); 2022; 13():1041808. PubMed ID: 36277718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study.
    Abdi A; Kohansal K; Khalili D; Azizi F; Hadaegh F
    Nutr Metab (Lond); 2024 Feb; 21(1):10. PubMed ID: 38389086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Rev Diabet Stud; 2011; 8(4):490-8. PubMed ID: 22580730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
    Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
    Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the extent of return to fasting state 2-hours after a glucose challenge with incident prediabetes and type 2 diabetes: The CARDIA study.
    Vivek S; Carnethon MR; Prizment A; Carson AP; Bancks MP; Jacobs DR; Thyagarajan B
    Diabetes Res Clin Pract; 2021 Oct; 180():109004. PubMed ID: 34391830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of fasting glucose for detection of prediabetes.
    Cheng C; Kushner H; Falkner BE
    Metabolism; 2006 Apr; 55(4):434-8. PubMed ID: 16546472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.